BridgeMD
New treatment option for Myopia
Official title Pharmacological and Non-pharmacological Treatment Effects on Children With Different Predicted Myopia Progression Rate
ClinicalTrials.gov ID: NCT06282848
What this study is testing
What is Atropine 0.05%?
Atropine 0.05% is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for myopia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare pharmacological and non-pharmacological treatment effects on the children with different predicted myopia progression rate measured by modified multifocal electroretinogram. The main questions it aims to answer are: the effectiveness of using 0.05% atropine and prescribing DIMS lens for myopia control in children with different myopia progression rates the contribution of L/M cones in juvenile myopia progression and changes of retinal activities under atropine and DIMS treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 9. Healthy volunteers may be eligible.
You may be able to join if
- be aged between 7 and 9 years
- have no reported eye disorder and no family history of eye disease
- be able to participate in this study for 24 months
- not have any current or history of epilepsy
- not have any current or history of asthma
See the full eligibility criteria
- be aged between 7 and 9 years
- have no reported eye disorder and no family history of eye disease
- be able to participate in this study for 24 months
- not have any current or history of epilepsy
- not have any current or history of asthma
- have refractive error between 0.50 D and 4.00 D and less than 1.50D of astigmatism with best corrected visual acuity of LogMAR 0.0 or better
- have no detected eye diseases or disorders after eye examination, except myopia
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 9 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.